Boston Scientific (BSX) PT Raised to $86 at Truist Securities

Go back to Boston Scientific (BSX) PT Raised to $86 at Truist Securities

Boston Scientific (BSX) PT Raised to $77 at Oppenheimer

April 25, 2024 10:00 AM EDT

Oppenheimer analyst Steven Lichtman raised the price target on Boston Scientific (NYSE: BSX) to $77.00 (from $68.00) while maintaining a Outperform rating.

The analyst comments "BSX delivered 1Q24 sales meaningfully ahead of the Street (13% organic y/y). EPS was also beat ($0.56 versus our/Street's... More

Boston Scientific (BSX) PT Raised to $82 at RBC Capital

April 25, 2024 6:40 AM EDT

RBC Capital analyst Shagun Singh raised the price target on Boston Scientific (NYSE: BSX) to $82.00 (from $78.00) while maintaining a Outperform rating.

The analyst comments "BSX delivered solid beat with an upside surprise of ~5% and ~10% on sales and EPS, respectively. Given this momentum (+660bps... More